PRANA BIOTECHNOLOGY LTD's ticker is PRAN and the CUSIP is 739727204. A total of 14 filers reported holding PRANA BIOTECHNOLOGY LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $98,000 | -2.0% | 49,043 | -8.2% | 0.00% | – |
| Q2 2018 | $100,000 | +566.7% | 53,443 | +620.2% | 0.00% | – |
| Q1 2018 | $15,000 | – | 7,421 | +742000.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2016 | $31,000 | -62.7% | 19,402 | +5.4% | 0.00% | – |
| Q3 2016 | $83,000 | – | 18,401 | +1840000.0% | 0.00% | – |
| Q2 2016 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claro Advisors LLC | 2,239 | $5,000 | 0.00% |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 1,115 | $1,000 | 0.00% |
| UBS Group AG | 10,111 | $13,000 | 0.00% |
| NEXT Financial Group, Inc | 583 | $1,000 | 0.00% |
| Advisor Group, Inc. | 2,512 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 267 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 218,410 | $280,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 74,622 | $96,000 | 0.00% |
| Citadel Advisors | 12,741 | $16,000 | 0.00% |